BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 38203502)

  • 1. Consideration of SHP-1 as a Molecular Target for Tumor Therapy.
    Lim S; Lee KW; Kim JY; Kim KD
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
    Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
    J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.
    Kim H; Baumann H
    Mol Cell Biol; 1999 Aug; 19(8):5326-38. PubMed ID: 10409724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel Src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma.
    Tai WT; Shiau CW; Chen PJ; Chu PY; Huang HP; Liu CY; Huang JW; Chen KF
    Hepatology; 2014 Jan; 59(1):190-201. PubMed ID: 23908138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1.
    Jiao H; Berrada K; Yang W; Tabrizi M; Platanias LC; Yi T
    Mol Cell Biol; 1996 Dec; 16(12):6985-92. PubMed ID: 8943354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells.
    Migone TS; Cacalano NA; Taylor N; Yi T; Waldmann TA; Johnston JA
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3845-50. PubMed ID: 9520455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Src homology 2 domain-containing tyrosine phosphatase (SHP-1) into lipid rafts inhibits CD3-induced T cell activation.
    Su MW; Yu CL; Burakoff SJ; Jin YJ
    J Immunol; 2001 Mar; 166(6):3975-82. PubMed ID: 11238643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
    Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel role of the C-terminal region of SHP-2. Involvement of Gab1 and SHP-2 phosphatase activity in Elk-1 activation.
    Huang Q; Lerner-Marmarosh N; Che W; Ohta S; Osawa M; Yoshizumi M; Glassman M; Yan C; Berk BC; Abe J
    J Biol Chem; 2002 Aug; 277(32):29330-41. PubMed ID: 12011040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)-1, and SHP-2 SH2 decoy proteins on Fc gamma RIIB1-effector interactions and inhibitory functions.
    Nakamura K; Brauweiler A; Cambier JC
    J Immunol; 2000 Jan; 164(2):631-8. PubMed ID: 10623804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raft-mediated Src homology 2 domain-containing proteintyrosine phosphatase 2 (SHP-2) regulation in microglia.
    Kim HY; Park SJ; Joe EH; Jou I
    J Biol Chem; 2006 Apr; 281(17):11872-8. PubMed ID: 16507579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of human protein tyrosine phosphatase SHP-1 in the open conformation.
    Wang W; Liu L; Song X; Mo Y; Komma C; Bellamy HD; Zhao ZJ; Zhou GW
    J Cell Biochem; 2011 Aug; 112(8):2062-71. PubMed ID: 21465528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidation sensitivity of the catalytic cysteine of the protein-tyrosine phosphatases SHP-1 and SHP-2.
    Weibrecht I; Böhmer SA; Dagnell M; Kappert K; Ostman A; Böhmer FD
    Free Radic Biol Med; 2007 Jul; 43(1):100-10. PubMed ID: 17561098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine SHP-1 splice variants with altered Src homology 2 (SH2) domains. Implications for the SH2-mediated intramolecular regulation of SHP-1.
    Martin A; Tsui HW; Shulman MJ; Isenman D; Tsui FW
    J Biol Chem; 1999 Jul; 274(31):21725-34. PubMed ID: 10419485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fyn kinase-directed activation of SH2 domain-containing protein-tyrosine phosphatase SHP-2 by Gi protein-coupled receptors in Madin-Darby canine kidney cells.
    Tang H; Zhao ZJ; Huang XY; Landon EJ; Inagami T
    J Biol Chem; 1999 Apr; 274(18):12401-7. PubMed ID: 10212213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SHP-1 tyrosine phosphatase binding to c-Src kinase phosphor-dependent conformations: A comparative structural framework.
    Gul M; Navid A; Fakhar M; Rashid S
    PLoS One; 2023; 18(1):e0278448. PubMed ID: 36638102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction.
    Li C; Friedman JM
    Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9677-82. PubMed ID: 10449753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular dynamics simulations on the free and complexed N-terminal SH2 domain of SHP-2.
    Wieligmann K; Pineda De Castro LF; Zacharias M
    In Silico Biol; 2002; 2(3):305-11. PubMed ID: 12542415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein tyrosine phosphatase SHP-2: a proto-oncogene product that promotes Ras activation.
    Matozaki T; Murata Y; Saito Y; Okazawa H; Ohnishi H
    Cancer Sci; 2009 Oct; 100(10):1786-93. PubMed ID: 19622105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
    Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
    Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.